인사이트

Insights From Our Experts

Articles

RWEsearch 2024 | Innovating Clinical Trial Design with Real World Evidence

At the RWEsearch Annual Summit 2024, hosted by Healthark Insights, Chris Cameron, Chief Scientific Officer at EVERSANA, emphasized that advancements in Real World Evidence will accelerate with ongoing learning and use of technology and AI.

Cutting-edge Insights from EVERSANA's Global Value & Evidence Team
Enhancing Quality of Life in Advanced Breast Cancer: The Role of Palbociclib

Advanced breast cancer often comes with significant physical symptoms, such as pain and fatigue, as well as side effects from treatments. The diagnosis and treatment of advanced breast cancer can lead to anxiety, depression and stress.…

Preparing for Joint Clinical Assessments
Preparing for Joint Clinical Assessments: How Early PICO Planning Ensures Smoother Submissions

Because the EU Health Technology Assessment (HTA) regulation will take effect in January 2025, pharmaceutical and medical device companies must prepare for a new era in health technology evaluations. The Joint Clinical Assessment (JCA), a core…

APACMed Digital Health Reimbursement Policy Forum 2024

Unlock the latest insights into AI-driven healthcare with APACMed’s 2024 Digital Health Reimbursement Policy Forum! This comprehensive white paper dives into key discussions from the event, where industry experts, policymakers, and thought leaders from across APAC,…

Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets
Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets

Are you interested in the latest developments in high-cost drug reforms across the EU4+UK markets? Our comprehensive paper, “Understanding Key Reforms for High-Cost Drugs in EU4+UK Markets,” delves into the intricate landscape of pharmaceutical pricing and…

Navigating India’s Rapidly Growing Obesity Market

Authors: Monica Gangwani, Executive Director India, Advisory Services, APAC Consulting; Gaurav Kolhekar, Senior Consultant, APAC Consulting; Utkarsh Sahu, Analyst, APAC Consulting India’s obesity market is rapidly expanding, driven by economic growth and lifestyle changes that have…

The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access

In today’s healthcare landscape, patients are no longer passive recipients of care. They are empowered, tech-savvy stakeholders who demand efficiency and transparency. Yet, despite advancements in consumer innovation, the healthcare system often leaves them frustrated with…

The Future of Global Commercialization: Unified, Data-Driven and Patient-Centric

Are you interested in the rapidly evolving pharmaceutical landscape? Do you want to understand the paradigm shift in global commercialization strategies? If so, we have just the resource for you! Download our latest article titled “The…

The Omnichannel Landscape in APAC’s Healthcare Industry
The Omnichannel Landscape in APAC’s Healthcare Industry

As the pharmaceutical industry in the Asia-Pacific (APAC) region undergoes a digital transformation, the shift towards an omnichannel strategy is reshaping how companies engage with healthcare professionals (HCPs). “The Omnichannel Landscape in APAC’s Healthcare Industry,” authored…

EVERSANA Experts On-Stage at Frontiers Health 2024

In anticipation of Frontiers Health 2024, EVERSANA is delighted to reveal that several of our key experts will be speaking at this top-tier global health innovation conference!  Scheduled for October 17-18th in Berlin, Germany, Frontiers Health…